4-Chloro-5-(chlorosulfonyl)-2-fluorobenzoic acid, 95.0%, 5g

8-Bromo-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one, 95%, 1g

Ethyl 3-oxo-4-(triphenylphosphoranylidene)butanoate, 95.0%, 25g

(5-Amino-2-methoxyphenyl)methanol, 95+%, 50mg

Flat flange reaction vial, cylindrical, graduated, with tempering jacket KF connecting piece, DN 100, 1000 ml, 130 mm, 1 Piece

2,5-Dioxopyrrolidin-1-yl 4-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)butanoate, 95.0%, 5g

(1-(P-tolyl)-1H-pyrazol-4-yl)boronic acid, 95.0%, 1g

3,4-Difluoro-2-ethoxyphenylboronic acid, 98%, 100mg

3-Oxo-pyrrolidine-1,2-dicarboxylic acid 1-benzyl ester 2-ethyl ester, 95.0%, 1g

(4-Methoxy-3,5-dimethylpyridin-2-yl)methanol, 97.0%, 10g

1-(6-Chloropyrazin-2-yl)-3-(6-methylpyridin-3-yl)urea, 250mg

1-(((1H-Benzo[d][1,2,3]triazol-1-yl)oxy)(piperidin-1-yl)methylene)piperidin-1-ium hexafluorophosphate(V), 95%, 10g

6-Bromo-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid, 250mg